Releafpeak Hemcare
NDC Package 78663-211-34

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Releafpeak Hemcare is adults and children 12 years of age and older: apply to the affected area not more than 3 to 4 times daily. Marketed by Releaf Technologies Llc, this product is identified by NDC 78663-211 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
78663-211-34
Package Description
100 mL in 1 TUBE
Product Code
78663-211
11-Digit Billing Format
78663021134

Clinical Specifications

Proprietary Name
Releafpeak Hemcare Maximum Relief
Dosage Form
-
Usage Information
Adults and children 12 years of age and older: apply to the affected area not more than 3 to 4 times daily. Children under 12 years of age: do not use, ask a doctor.

Regulatory & Marketing

Labeler Name
Releaf Technologies Llc
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-09-2023
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 78663-211-34 identifies a specific commercial package of 100 ml in 1 tube of Releafpeak Hemcare Maximum Relief, labeled by Releaf Technologies Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Releaf Technologies Llc on November 09, 2023. The current certification is valid through December 31, 2024.

How is this Releaf Technologies Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 78663021134. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
78663-211-34
11-Digit CMS (5-4-2)
78663-0211-34

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.